Estrella Immunopharma (ESLA) Ownership Overview
1.75% Insiders
1.09% Mutual Funds
9.14% Other Institutional Investors
1.07% ETFs
86.94% Public Companies and
Individual Investors
The ownership structure of Estrella Immunopharma (ESLA) stock is a mix of institutional, retail, and individual investors. Approximately 11.31% of the company’s stock is owned by Institutional Investors, 1.75% is owned by Insiders, and 86.94% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 29, 2026 | xxxxxxxxxxxxx | $2594 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 416,852 | Institution | 0.96% | 265,952 | |
| 397,437 | Insider | 0.91% | 253,565 | |
| 382,469 | Institution | 0.88% | 244,015 | |
| 365,488 | Insider | 0.84% | 233,181 | |
| 93,534 | Institution | 0.22% | 59,675 | |
| 49,660 | Institution | 0.11% | 31,683 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 382,469 | Institution | 0.88% | 244,015 | |
| 93,534 | Institution | 0.22% | 59,675 |
Top ETF Holders
FAQ
Who Owns Estrella Immunopharma (ESLA)?
According to the latest TipRanks data, approximately 9.14% of the company's stock is held by institutional investors, 1.75% is held by insiders, and 86.94% is held by retail investors.
What percentage of Estrella Immunopharma (ESLA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.14% of Estrella Immunopharma (ESLA) stock is held by institutional investors.
What percentage of Estrella Immunopharma (ESLA) stock is held by retail investors?
According to the latest TipRanks data, approximately 86.94% of Estrella Immunopharma (ESLA) stock is held by retail investors.
Who owns the most shares of Estrella Immunopharma (ESLA)?
Vanguard owns the most shares of Estrella Immunopharma (ESLA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.